unknown
Stage
About
Atara Biotherapeutics develops allogeneic T-cell immunotherapies designed to treat cancer and autoimmune diseases by harnessing off-the-shelf T-cell therapies derived from healthy donors.
Explore Atara Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.